News

In a study published at the end of August in the journal Molecular Therapy, Michael Kaminski, Verena Klämbt, and Matteus Krappitz – all participants of the BIH Charité Clinician Scientist Program – report an advancement in the fight against autosomal dominant polycystic kidney disease (ADPKD). The…

Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000 people in Germany suffer from the disease. Many struggle to access appropriate care, especially if they need complex immunotherapies. The start-up…

Gemeinsame Pressemitteilung der Charité und des BIH.